Inhibition of growth and induction of differentiation of metastatic melanoma cells in vitro by genistein: chemosensitivity is regulated by cellular p53

British Journal of Cancer
S RauthA Green

Abstract

We have investigated the effect of the soybean isoflavone genistein on the growth and differentiation of human melanoma cells. Four human melanoma cell lines, either completely lacking or containing different levels of wild-type p53, were treated with genistein in vitro in culture. It has been found that genistein significantly inhibited cell growth and that the chemosensitivity might depend on cellular p53 content. Specifically, the data suggest that high levels of wild-type p53 expression make cells resistant to genistein's growth-inhibitory action. Further support for this observation came from the stable transfection studies in which p53 transfectants expressing high levels of wild-type p53 became resistant to genistein. With respect to cell differentiation, our study showed that genistein increased melanin content and tyrosinase activity and caused the cells to form dendrite-like structures. Cells lacking p53 responded more than cells with p53 to dendrite-like structure formation. We also observed that genistein-induced differentiation involved an increase in tyrosinase mRNA level; the mechanisms by which genistein increases tyrosinase transcripts remain to be elucidated. Genistein treatment of the melanoma cell lines resu...Continue Reading

Citations

Mar 24, 2011·Pigment Cell & Melanoma Research·Deeba N Syed, Hasan Mukhtar
Dec 5, 2012·Journal of Natural Medicines·Ippei HoribeYasuo Nagaoka
Mar 23, 2018·International Journal of Molecular Sciences·Chau Yee NgShih-Chi Su
Oct 18, 2002·Proceedings of the National Academy of Sciences of the United States of America·Chang-Jun LiuRichard A Dixon
Mar 2, 2006·Current Oncology Reports·Toni K ChoueiriTarek M Mekhail
Jul 17, 2010·Retina·Tito FioreCarlo Cagini
Jun 1, 1999·Nutrition Research Reviews·J J AndersonS C Garne
Mar 28, 1998·Breast Cancer Research and Treatment·S Barnes
Feb 22, 2007·Chemistry & Biodiversity·Li-Na ZhangRen-Xiang Tan
Oct 31, 2000·Bioscience, Biotechnology, and Biochemistry·K IwashitaT Tsushida
Nov 12, 2016·Frontiers in Endocrinology·Monica MarzagalliPatrizia Limonta
Sep 9, 1999·The American Journal of Clinical Nutrition·M J Messina
Jan 24, 2007·Acta Pharmacologica Sinica·Wen-hsiung ChanNion-heng Shiao
Mar 29, 2011·Critical Reviews in Toxicology·Susanne AndresAlfonso Lampen
Nov 4, 2000·Expert Opinion on Investigational Drugs·H K Wang
Dec 16, 2018·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Javed IqbalAkhtar Munir
Oct 29, 1998·Biochemical and Biophysical Research Communications·T KuzumakiK Ishikawa
Oct 8, 1998·Advances in Enzyme Regulation·G WeberH Yang
Jul 18, 2002·The Journal of Nutritional Biochemistry·Hong Zhong WangRong Qing Zhang
Jun 29, 1999·Baillière's Clinical Endocrinology and Metabolism·S Barnes
Jun 29, 1999·Baillière's Clinical Endocrinology and Metabolism·M Messina, M Bennink

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis